- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index
Diagnosis and management of inhalation injury
cous plugging, and increased secretions. The prevention of pneumonia involves meticulous pulmonary hygiene, use of specialized ventilator modes (such as percussive ventilation), and frequent bronchoscopy both for diagnosis and to clear debris. The use of prophylactic antibiotics is not recommended, as this practice may predispose to the development of more virulent organisms. Clinicians need to remain vigilant and monitor patients closely for the development of pneumonia. Early aggressive evaluation of pneumonia via bronchoalveolar lavage will facilitate the use of appropriate antibiotic therapy. Common organisms isolated from burn/inhalation injury patients vary widely. Infections reported include the SPACE group (Serratia, Pseudomonas aeruginosa, Acinetobacter, Citrobacter, and Enterobacter species), methicillin resistant Staphylococcus aureus (MRSA), and other (Hemophilus influenzae, Streptococcus, Klebsiella) [91].
One potential method for decreasing the incidence of pneumonia while providing definitive airway management after inhalation injury is tracheostomy. Early tracheostomy, which decreases dead space, improves laminar flow, and allows for improved pulmonary toilet, has been shown to be of benefit in children requiring greater than 10 days of intubation in several studies [92, 93]. However, a single center study in adults did not confirm these findings [94]. The use of tracheostomy is generally recommended for patients with major burn injury ( > 50% TBSA) involving the face who will require mechanical ventilation for > 10 days.
The use of steroids in inhalation injury has been controversial. Several studies performed in the 1970s and 1980s demonstrated increased infection rates in patients treated with steroids [95–97]. More recent studies have not shown any benefits to steroid administration after inhalation injury [98, 99]. As such, the use of steroids after inhalation injury is not recommended.
Nutrition after burn and inhalation injury may also contribute to patient outcomes. The early institution of enteral nutrition has been shown to decrease infection rates and improve mortality in patients with inhalation injury compared to intravenous nutrition [100]. The primary route of nutrition for patients with burn/inhalation injury should thus be enteral, and parenteral nutrition should be avoided. To date there
is little evidence that immune enhancing enteral formulas provide improvements in infectious rate or mortality in burn/inhalation injury [101].
Prognosis
Inhalation injury is one of the most important predictors of morbidity and mortality in burn patients. When present, INH-INJ increases mortality in up to 15 times [1, 2]. INH-INJ requires endotracheal intubation, which in turn increases the incidence of pneumonia.
As mentioned before, pneumonia is a common complication of INH-INJ, and increases mortality in up to 60% in these patients [2]. Patients usually recover full pulmonary function and late complications are not the rule. Complications can be secondary to the INH-INJ or to the endotracheal or tracheostomy tube. Hyper-reactive airways and altered patterns on pulmonary function (obstructive and restrictive) have been described following INH-INJ [5]. Scarring of the airway can cause stenosis and changes in the voice, requiring voice therapy and occasionally surgery.
Conclusions
The evaluation, diagnosis, and treatment of the three types of inhalation injury continue to challenge both experienced and inexperienced practitioners. Although the evaluation of each type of inhalation injury have the same foundation, there are subtle, but significant differences among the three. In addition, the various forms of inhalation injury do not occur in isolation. For example, patients with carbon monoxide toxicity will often have concomitant upper or lower airway injury, as well. Management of each of the forms of injury vary. Inhaled gas exposure requires attention to resuscitation and oxygenation, upper airway injury requires intubation until airway edema resolves, and lower airway injury may require extended periods of mechanical ventilation to maintain ventilation and oxygenation for ALI/ARDS. Finally, prognosis varies based on the extent and type of inhalation injury involved. Timely diagnosis and treatment thus remain the key to improving outcomes in patients with inhalation injury.
169
T. L. Palmieri, R. L. Gamelli
References
[1]Tredget EE, Shankowshy HA, Taerum TV, Moysa GL, Alton JD (1990) The role of inhalation injury in burn trauma. A Canadian Experience. Ann Surg 212: 720–727
[2]Saffle JR, Davis B, Williams P (1995) Recent outcomes in the treatment of burn injury in the United States: A report from the American Burn Association patient registry. J Burn Care Rehabil 16: 219–232
[3]Smith DL, Cairns BA, Ramadan F et al (1994) Effect of inhalation injury, burn size, and age on mortality: a study
of 1447 consecutive burn patients. J Trauma 37: 655–659 [3a] Traber DL, Herndon DN, Enkhbaatar P et al (2007) The pathophysiology of inhalation injury. In: Herndon DN (ed) Total burn care, 3rd edn. Saunders, Elsevier, Phila-
delphia, PA, pp 248–261
[4]Shirani KZ, Pruitt Ba Jr, Mason AD Jr (1987) The influence of inhalation injury and pneumonia on burn mortality. Ann Surg 205: 82–87
[5]Sellersk BJ, Davis BL, Larkin PW, Morris SE, Saffle JR (1997) Early prediction of prolonged ventilator dependence in thermally injured patients. J Trauma
43: 899–903
[5a] Nugent N, Herndon DN (2007) Diagnosis and treatment of inhalation injury. In: Herndon DN (ed) Total burn care, 3rd edn. Saunders, Elsevier, Philadelphia, PA, pp 262–272
[6]Traber DL, Herndon DN, Soejima K (2002) The pathophysiology of inhalation injury. In: Herndon DN (ed) Total burn care, 2nd edn. W. B. Saunders, London, pp 221–231
[7]Birke MM, Clarke FB (1981) Inhalation of toxic products from fires. Bull NY Acad Med 57: 997–1013
[8]Centers for Disease Control and Prevention. Carbon monoxide-related deaths-United States, 1999–2004. 2007; 56: 1309–1310.
[9]Weaver LK (1999) Carbon monoxide poisoning. Crit Care Clin 15: 297–317
[10]Hardy KR, Thom SR (1994) Pathophysiology and treatment of carbon monoxide poisoning. J Clin Tox 32(6): 613–629
[11]Demling RH (1995) Burn care in the immediate resuscitation period. Scientific American Surgery, New York, pp 1–16
[12]Jasper BW, Hopkins RO, Duker HV, Weaver LK (2005) Affective outcome following carbon monoxide poisoning: prospective longitudinal study. Cogn Behav Neur 18(2): 127–134
[13]Hardy KR, Thom SR (1994) Pathophysiology and treatment of carbon monoxide poisoning. J Clin Tox 32(6): 613–629
[14]Crapo RO (1981) Smoke-Inhalation injuries. JAMA 246: 1694–696
[15]Hart GB, Strauss MB, Lennon PA, Whitcraft D III (1985) Treatment of smoke inhalation by hyperbaric oxygen. J Emerg Med 3: 211–215
[16]Mathieu D, Wattel F, Mathieu-Nolf M, Durak C et al (1996) Randomized prospective study comparing the effect of HBO vs. 12 hours NBO in non-comatose COpoisoned patients: results of the preliminary analysis. Undersea Hyperbar Med 23 [Suppl]: 7 (abstract)
[17]Raphael JC, Elkharrat D, Jars-Guincestre M-C, Chastang C et al (1989) Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet 2: 414–419
[18]Raphael JC, Chevret S, Driheme A, Annane D (2004) Managing carbon monoxide poisoning with hyperbaric oxygen (abstract). J Toxicol-Clin Tox 42: 455–456
[19]Scheinkestel CD, Bailey M, Myles PS, Jones K et al (1999) Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomized controlled clinical trial. Med J Austral 170: 203–210
[20]Thom SR, Taber RL, Mendiguren II, Clark JM et al (1995) Delayed neurologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emer Med 25: 474–480
[21]Clark CJ, Campbell D, Reid WH (1981) Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet 1: 1332–1335
[22]Woolley WD (1972) Nitrogen containing products from the thermal decomposition of flexible polyurethane foams. Br Polymer J 4: 27–43
[23]Bell RH, Stemmer KL, Barkley W, Hollingsworth LD (1979) Cyanide toxicity from the thermal degradation
of rigid polyurethane foam. Am Ind Hyg Assoc J 40: 757–762
[24]Terrill JB, Montgomery RR, Reinhardt CF (1978) Toxic gases from fires. Science 200: 1343–1347
[25]Cahalane M, Demling RH (1984) Early respiratory abnormalities from smoke inhalation. JAMA 251: 771–773
[26]Fein A, Leff A, Hopewell PC (1980) Pathophysiology and management of the complications resulting from fire and the inhaled products of combustion: review of the literature. Crit Care Med 8: 94–98
[27]Burgess WA, Treitman RD, Gold A (1979) Air contaminants in structural firefighting. Springfield, VA: National Technical Information Service Publication PB 299 017, US Dept of Commerce
[28]Silverman SH, Purdue GF, Hunt JL, Bost RO (1988) Cyanide toxicity in burned patients. J Trauma 28: 171–176
[29]Clark CJ, Campbell D, Reid WH (1981) Blood carboxyhaemoglobin and cyanide levels in fire survivors. Lancet 1: 1332–1335
[30]Wetherell HR (1966) The occurrence of cyanide in the blood of fire victims. J Forensic Sci 11: 167–173
[31]Barillo DJ, Goode R, Rush BF, Lin RL, Freda A, Anderson EJ (1986) Lack of correlation between carboxyhemoglobin and cyanide in smoke inhalation injury. Curr Surg 43: 421–423
[32]Barillo DJ, Rush BF, Goode R, Lin RL, Freda A, Anderson EJ (1986) Is ethanol the unknown toxin in smoke inhalation injury? Am Surg 52: 641–645
170
Diagnosis and management of inhalation injury
[33]Anderson RA, Harland WA (1982) Fire deaths in the Glasgow area: III the role of hydrogen cyanide. Med Sci Law 22: 35–40
[34]Ballantyne B (1983) Artifacts in the definition of toxicity by cyanides and cyanogens. Fundam Appl Toxicol 3: 400–408
[35]Hall AH, Rumack BH (1986) Clinical toxicology of cyanide. Ann Emerg Med 15: 1067–1074
[36]Ivankovich AD, Braverman B, Kanuru RP, Heyman HJ, Paulissian R (1980) Cyanide antidotes and methods of their administration in dogs: a comparative study. Anesthesiology 52: 210–216
[37]Curry AS, Price DE, Rutter ER (1967) The production of cyanide in post mortem material. Acta Pharmacol et Toxicol 25: 339–344
[38]Gettler AO, Baine JO (1938) The toxicology of cyanide. Am J Med Sci 195: 182–198
[39]Graham DL, Laman D, Theodore J, Robin ED(1977) Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med 137: 1051–1055
[40]Jones J, McMullen MJ, Dougherty J (1987) Toxic smoke inhalation: cyanide poisoning in fire victims. Am J Emerg Med 5: 317–321
[41]Hartzell GE (1991) Combustion products and their effects on life safety. In: Cote AE, Linville JL (eds) Fire protection handbook, 17th edn. National Fire Protection Association, Quincy, MA
[42]Hall AH, Rumack BH (1986) Clinical toxicology of cyanide. Ann Emerg Med 15: 1067–1074
[43]Cohen MA, Guzzardi L (1984) A letter on the treatment of cyanide poisoning. Vet Hum Toxicol 26: 503–504
[44]Vogel SN, Sultan TR, Ten Eyck RP (1981) Cyanide poisoning. Clin Toxicol 18: 367–383
[45]Graham DL, Laman D, Theodore J, Robin ED (1977) Acute cyanide poisoning complicated by lactic acidosis and pulmonary edema. Arch Intern Med 137: 1051–1055
[46]Caravati EM, Litovitz TL (1988) Pediatric cyanide intoxication and death from an acetonitrile-containing cosmetic. JAMA 260: 3470–3472
[47]Brivet F, Delfraissy JF, Duche M, Bertrand P, Dormont J (1983) Acute cyanide poisoning: recovery with nonspecific supportive therapy. Intensive Care Med 9: 33–35
[48]Pettigrew AR, Fell GS (1972) Simplified colorimetric determination of thiocyanate in biological fluids, and its application to investigation of the toxic amblyopias. Clin Chem 18: 996–1000
[49]Vincent M, Vincent F, Marka C, Faure J (1981) Cyanide and its relationship to nervous suffering. Physiopathological aspects of intoxication. Clin Toxicol 18: 1519–1527
[50]Cottrell JE, Casthely P, Brodie JD, Patel K, Klein A, Turndorf H (1978) Prevention of nitroprusside-in- duced cyanide toxicity with hydroxocobalamin. N Engl J Med 298: 809–811
[51]Hall AH, Dart R, Bogdan G (2007) Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Em Med 49: 806–813
[52]Borron SW (2006) Recognition and treatment of acute cyanide poisoning. J Em Nursing 32: S12-S18
[53]Erdman AR (2007) Is hydroxocobalamin safe and effective for smoke inhalation? Searching for guidance in the haze. Ann Em Med 49: 814–816
[54]DesLauriers CA, Burda AM, Whal M (2006) Hydroxocobalamin as a cyanide antidote. Am J Therapeutics
13:161–165
[55]Borron SW, Baud FJ, Megarbane B, Chantal B (2007) Hydroxocobalamin for severe acute cyanide poisoning by ingestion or inhalation. Am J Emerg Med 25: 551– 558
[56]Hall AH, Rumack BH (1986) Clinical toxicology of cyanide. Ann Emerg Med 15: 1067–1074
[57]Langford RM, Armstrong RF (1989) Algorithm for managing injury from smoke inhalation. BMJ 299: 902–905
[58]Ivankovich AD, Braverman B, Kanuru RP, Heyman HJ, Paulissian R (1980) Cyanide antidotes and methods of their administration in dogs: a comparative study. Anesthesiology 52: 210–216
[59]Levine MS, Radford EP (1978) Occupational exposures to cyanide in Baltimore fire fighters. J Occup Med
20:53–56
[60]Hall AH, Kulig KW, Rumack BH (1989) Suspected cyanide poisoning in smoke inhalation: complications of sodium nitrite therapy. J Toxicol Clin Exp 9: 3–9
[61]Cottrell JE, Casthely P, Brodie JD, Patel K, Klein A, Turndorf H (1978) Prevention of nitroprusside-induced cyanide toxicity with hydroxocobalamin. N Engl J Med
298:809–811
[62]Garnier R, Bismuth C, Riboulet-Delmas G, Efthymiou ML (1981) Poisoning from fumes from polystyrene fire. BMJ 283: 1610–1611
[63]Friedl HP, Till GO, Trentz O, Ward PA (1989) Roles of histamine, complement and xanthine oxidase in thermal injury of skin. Am J Pathol 135: 203–217
[64]Ward PA, Till GO (1990) Pathophysiologic events related to thermal injury of skin. J Trauma 30: 575–579
[65]Oldham KT, Guice KS, Till GO, Ward PA (1988) Activation of complement by hydroxyl radical in thermal injury. Surgery 104: 272–279
[66]Granger D, Rutili G, McCord J (1981) Superoxide radicals in feline intestinal ischemia. Gastroenterology 81: 22–29
[67]Mlcak RP, Suman OE, Herndon DN (2007) Respiratory management of inhalation injury. Burns 33: 2–13
[68]Fitzpatrick JC, Cioffi WG (1997) Ventilatory Support following burns and smoke inhalation injury. Respir Care Clin N Am 3: 21–49
[69]Cook DJ, Kollef MH (1998) Risk factors for ICU-ac- quired pneumonia. JAMA 279: 1605–1606
[70]Cook DJ, Walter SD, Cook RJ, Griffith GH et al (1998) Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Int Med
129:433–440
171
T. L. Palmieri, R. L. Gamelli
[71](2004) American Burn Association. Airway management and smoke inhalation injury. In Advanced Burn Life Support Manual. Chicago. American Burn Association, pp 16–20
[72]Drakulovic MB, Torres A, Bauer TT, Nicolas JM et al (1999) Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients. Lancet 354: 1851–1858
[73]Carvajal HF, Linares HA, Brouhard BH (1979) Relationship of burn size to vascular permeability changes in rates. Surg Gynecol Obstet 149: 193–202
[74]Harms BA Bodai BI, Kramer GC, Demling RH (1982) Microvascular fluid and protein flux in pulmonary and systemic circulations after thermal injury. Microvasc Res 23: 77–86
[75]Ward PA, Till GO (1990) Pathophysiologic events related to thermal injury of skin. J Trauma 30:S75–79
[76]Smith DL, Cairns BA Ramadan F et al (1994) Effect of inhalation injury, burn size, and age on mortality: A study of 1447 consecutive burn patients. J Trauma 37: 655–659
[77]Wyncoll DL, Evans TW (1999) Acute respiratory distress syndrome. Lancet 354: 497–501
[78]Pruitt BA Jr, Cioffi WG, Shimazu T, Ikeuchl H et al (1990) Evaluation and management of patients with inhalation injury. J Trauma 30:S63–68
[79]Cioffi WG, DeLemos RA, Coalson JJ et al (1993) Decreased pulmonary damage in primates with inhalation injury treated with high-frequency ventilation. Ann Surg 218: 328–337
[80]Rodeberg DA, Housinger TA, Greenhalgh DG et al (1994) Improved ventilatory function in burn patients using volumetric diffusive respiration. J Am Coll Surg 179: 518–522
[81]Carman B, Cahill T, Warden G et al (2001) A prospective, randomized comparison of the volume diffusive respirator vs. conventional ventilation for ventilation of burned children. JBCR 13: 444–448
[82]Enkhbaatar P, Cox R, Traber LD et al (2007) Aerosolized anticoagulants ameliorate acute lung injury in sheep after exposure to burn and smoke inhalation. Crit Care Med 12: 2805–2810
[83]Morita N, Traber MG, Enkhbaatar P, Westphal M, Murakami K et al (2006) Aerosolized alpha-tocopherol ameliorates acute lung injury following combined burn and smoke inhalation injury in sheep. Shock 25: 277–282
[84]Palmieri TL (2009) Use of beta-agonists in inhalation injury. J Burn Care Res 30: 156–159
[85]Musgrave MA, Fingland R, Gomez M, Fish J, Cartotto R (2000) The use of inhaled nitric oxide as adjuvant therapy in patients with burn injuries and respiratory failure. J Burn Care Rehabil 21(6):551–557
[87]Sheridan RL, Hurford WE, Kacmarek RM, Ritz RH, Yin LM, Ryan CM, Tompkins RG (1997) Inhaled nitric oxide in burn patients with respiratory failure. J Trauma 42(4):629–634
[88]Naver PD, Saffle JR, Warden GD (1986) Effect of inhalation injury on fluid resuscitation requirements after thermal injury. J Plast Reconstr Surg 78: 550
[89]Herndon DN, Traber DL, Traber LD (1986) The effect of resuscitation on inhalation injury. Surgery 100: 248– 251
[90]Rue LW, Cioffi WG, Mason A, McManus W, Pruitt BA (1995) The risk of pneumonia in thermally injured patients requiring ventilatory support. J Burn Care Res
16:262–268
[91]Wahl WL, Taddonio MA, Arbabi S, Hemmila MR (2009) Duration of antibiotic therapy for ventilator-associat- ed pneumonia in burn patients. J Burn Care Res
30:801–806
[92]Barret JP, Desai MH, Herndon DN (2000) Effects of tracheostomies on infection and airway complications in pediatric burn patients. Burns 26: 190–193
[93]Palmieri TL, Jackson W, Greenhalgh DG (2002) Benefits of early tracheostomy in severely burned children. Crit Care Med 30: 922–924
[94]Saffle JR, Morris SE, Edelman LE (2002) Early tracheostomy does not improve outcome in burn patients. J Burn Care Res 23: 431–438
[95]Moylan JA, Alexander LG Jr (1978) Diagnosis and treatment of inhalation injury. World J Surg 2: 185–191
[96]Levine BA, Petroff PA, Slade CL et al (1978) Prospective trials of dexamethasone and aerosolized gentamicin in the treatment of inhalation injury in the burned patient. J Trauma 18: 188–93
[97]Robinson NB, Hudson LD, Riem M et al (1982) Steroid therapy following isolated smoke inhalation injury. J Trauma 22: 876–879
[98]Cha SI, Kim CH, Lee JH et al (2007) Isolated smoke inhalation injuries: Acute respiratory dysfunction, clinical outcomes, and short-term evolution of pulmonary functions with the effects of steroids. Burns 33: 200–208
[99]Nieman GF, Clark WF, Hakim T (1991) Methylprednisolone does not protect the lung from inhalation injury. Burns 17: 384–390
[100]Herndon DN, Barrow RE, Stein M, Linares H et al (1989) Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Res 10: 309–313
[101]Saffle JR, Wiebke G, Jennings K, Morris SE et al (1997) Randomized trial of immune-enhancing nutrition in burn patients. J Trauma 42: 793–802
[86]Sheridan RL, Zapol WM, Ritz RH, Tompkins RG (1999) Correspondence: Tina L. Palmieri M.D., FACS, FCCM, Shriners Low-dose inhaled nitric oxide in acutely burned chilHospital for Children Northern California and University of
dren with profound respiratory failure. Surgery |
California Davis, 2425 Stockton Blvd, Suite 718, Sacramento, |
126(5): 856–862 |
CA 95 817, USA, E-mail: tina.palmieri@ucdmc.ucdavis.edu |
172